BSE
2300.00
NSE
2307.90
Media
Contact Us
India
USA
UK
South Africa
Australia
Philippines
Germany
Netherlands
Mexico
Brazil
Canada
Switzerland
About Us
About Us
Overview
Our Story
Our Purpose
Our Values
Our Governing Principles
Global Manufacturing
Research and Development (R&D)
Global Presence
Our Leadership
Awards and Recognition
Our Offering
Products
Overview
Key Therapeutic Areas
Generics
Product Finder
Tech-Driven Offerings
Biosimilars
Specialty
Over-the-Counter
Biotech CDMO
Active Pharmaceutical Ingredients (API)
Global Institutional Business
Lupin Manufacturing Solutions
Investors
Investors
Overview
Financials
Reports & Filings
Committees of the Board
Code of Conduct
Policies
Shareholder Information
Memorandum & Articles of Association
Employee Stock Option Schemes
News & Events
Business Responsibility
Analyst Coverage
Investor FAQs
Community
Careers
BSE
2300.00
NSE
2307.90
Media
Contact Us
India
USA
UK
South Africa
Australia
Philippines
Germany
Netherlands
Mexico
Brazil
Canada
Switzerland
About Us
About Us
Overview
Our Story
Our Purpose
Our Values
Our Governing Principles
Global Manufacturing
Research and Development (R&D)
Global Presence
Our Leadership
Awards and Recognition
Our Offering
Products
Overview
Key Therapeutic Areas
Generics
Product Finder
Tech-Driven Offerings
Biosimilars
Specialty
Over-the-Counter
Biotech CDMO
Active Pharmaceutical Ingredients (API)
Global Institutional Business
Lupin Manufacturing Solutions
Investors
Investors
Overview
Financials
Reports & Filings
Committees of the Board
Code of Conduct
Policies
Shareholder Information
Memorandum & Articles of Association
Employee Stock Option Schemes
News & Events
Business Responsibility
Analyst Coverage
Investor FAQs
Community
Careers
Category:
Press Releases
Press Releases
Lupin finalizes patent sale agreement with Servier
April 5, 2006
Read more
Press Releases
Lupin-Aspen sign Joint Venture
February 27, 2006
Read more
Press Releases
Lupin LCTL Divestment
February 27, 2006
Read more
Press Releases
Lupin to Reorganise Sale Structure for Suprax
February 21, 2006
Read more
Press Releases
Lupin sells Intellectual Property on Perindopril to Servier
February 20, 2006
Read more
Press Releases
Lupin receives US FDA approval for Sertraline
February 7, 2006
Read more
Press Releases
Lupin and Aspen decide not to pursue their MOU
January 19, 2006
Read more
Press Releases
Lupin FY 2006-07 Q3 Net Profit up by 27 % at Rs. 560 mn
January 17, 2006
Read more
Press Releases
Lupin gets tentative US FDA approval for Sertraline
January 2, 2006
Read more
Press Releases
Lupin launches novel cholesterol-fighter EZEDOC
December 20, 2005
Read more
1
2
…
96
97
98
…
102
103
Search
Hit enter to search or ESC to close
Your shopping cart
Cart